Dr Alexandros Kanellopoulos | Neuroscience | Best Researcher Award

Posted on by sciencefather

Dr Alexandros Kanellopoulos Neuroscience | Best ResearcherAward  🏆

Principal Scientist of Cognitive Health at DSM-Firmenich, RD Innovation
Switzerland🎓

Alexandros Kanellopoulos is a seasoned Innovation Leader, Principal Scientist, and Clinical Director with over 20 years of expertise in Neuroscience, Metabolism, Early Life Nutrition (ELN), and Medical Nutrition. He has successfully led multidisciplinary teams, pioneered product innovations, and authored more than 20 high-impact publications. With 7 patents to his name, Alexandros excels in transforming scientific research into tangible solutions that meet market needs.

Professional Profile 

Education

Alexandros Kanellopoulos holds a Ph.D. in Neuroscience from Kapodistrian University, Greece (2008-2013), where his research focused on neurodevelopmental disorders. Prior to this, he completed his M.Sc. in Molecular Medicine (Neuroscience) at the same university (2005-2007), gaining advanced expertise in neuroscience and molecular biology. His academic foundation was established with a B.Sc. in Molecular Biology and Genetics from Dimocritus University of Thrace, Greece (2000-2005), where he developed a strong background in genetics and molecular biology.

Work Experience

In his current role as Global Principal Scientist & Clinical Director at DSM-Firmenich (2023-Present), Alexandros oversees scientific activities, driving innovation in dietary supplements and medical nutrition. Prior to this, he worked as an R&D Innovation Scientist and Project Manager at Nestle SA (2022-2023), leading the development of brain health products for Early Life Nutrition. In 2023, he also held the position of Medical, Scientific & Regulatory Affairs Manager at Nestle Nutrition, focusing on market communication and regulatory compliance. Alexandros previously served as Group Leader, Early Life Brain Metabolism at the University of Lausanne (2020-2022) and as Senior Scientist in Early Life Neuroscience (2016-2020), where he pioneered research in neurodevelopmental disorders.

Skills 

Alexandros is highly skilled in Innovation & Product Development, leading projects from concept to market. He is an expert in Clinical Research & Protocol Design, managing complex preclinical and clinical trials. His ability to lead multidisciplinary teams and drive Cross-functional Collaboration is complemented by his talent for Stakeholder Engagement & Market Alignment, ensuring alignment between research innovations and market needs. His Strategic Thinking, Problem-solving, and Emotional Intelligence are key to his success in high-impact research and business projects.

Awards & Honors

Throughout his career, Alexandros has earned more than 15 research awards, securing CHF 2.5 million in research funding. He has been awarded 7 patents as an inventor, reflecting his contributions to innovation in neuroscience and nutrition. In addition, he has delivered over 40 invited presentations at international conferences, establishing himself as a respected thought leader in his field.

 Membership 

Alexandros contributes to the scientific community as a Reviewer for leading neuroscience journals and serves as an Editor in scientific publications, ensuring the dissemination of high-quality research.

Teaching Experience

Alexandros is also an experienced educator, having delivered lectures in Neuroscience and Medical Sciences at the University of Lausanne and Kapodistrian University, Athens. In his academic roles, he has mentored over 20 junior scientists, fostering the next generation of researchers and innovators.

Research Focus

Alexandros’ research centers on Early Life Nutrition and its role in brain development. He is particularly focused on Neurodevelopmental Disorders such as Autism and Fragile X Syndrome. His work on Brain Energy Metabolism and Mitochondrial Function provides insights into neurotransmission and social behavior. Alexandros has also designed Preclinical and Clinical Research aimed at developing nutritional solutions to address these complex medical challenges.

Publications : 

  • Activation of the 5-HT1A Receptor by Eltoprazine Restores Mitochondrial and Motor Deficits in a Drosophila Model of Fragile X Syndrome
    🧠 International Journal of Molecular Sciences – 2024
    DOI: 10.3390/ijms25168787
  • Aralar Sequesters GABA into Hyperactive Mitochondria, Causing Social Behavior Deficits
    🧬 Cell – 2020
    DOI: 10.1016/j.cell.2020.02.044
  • Conserved Tao Kinase Activity Regulates Dendritic Arborization, Cytoskeletal Dynamics, and Sensory Function in Drosophila
    🔬 The Journal of Neuroscience – 2020
    DOI: 10.1523/jneurosci.1846-19.2020
  • Domain-Specific Cognitive Impairments in Humans and Flies With Reduced CYFIP1 Dosage
    🧩 Biological Psychiatry – 2019
    DOI: 10.1016/j.biopsych.2019.04.008
  • SynGO: An Evidence-Based, Expert-Curated Knowledge Base for the Synapse
    🧠 Neuron – 2019
    DOI: 10.1016/j.neuron.2019.05.002
  • Mitochondrial Dysfunction in Autism Spectrum Disorder: Clinical Features and Perspectives
    🧠 Current Opinion in Neurobiology – 2017
    DOI: 10.1016/j.conb.2017.05.018
  • Autism Spectrum Disorders: Translating Human Deficits into Mouse Behavior
    🐁 Neurobiology of Learning and Memory – 2015
    DOI: 10.1016/j.nlm.2015.07.013
  • Learning and Behavioral Deficits Associated with the Absence of the Fragile X Mental Retardation Protein: What a Fly and Mouse Model Can Teach Us
    🧠 Learning & Memory (Cold Spring Harbor, N.Y.) – 2014
    DOI: 10.1101/lm.035956.114
  • Learning and Memory Deficits Resulting from Reduction of the Fragile X Mental Retardation Protein: A Metabotropic Glutamate Receptor-Mediated Inhibition of cAMP Signaling in Drosophila
    🧠 The Journal of Neuroscience – 2012
    DOI: 10.1523/JNEUROSCI.1347-12.2012
  • Selective Serotonin Reuptake Inhibitors for the Treatment of Hypersensitive Esophagus: A Randomized, Double-blind, Placebo-controlled Study
    💊 The American Journal of Gastroenterology – 2011
    DOI: 10.1038/ajg.2011.179

Dr Andreu Massot Tarrús | Neuroscience | Best Researcher Award

Posted on by sciencefather

Dr Andreu Massot Tarrús | Neuroscience | Best Researcher Award 🏆

Neurologist at Hospital Universitari Mútua Terrassa, Spain🎓

Andreu Massot Tarrús, MD, PhD, is a highly accomplished neurologist and epileptologist with over 20 years of experience. He earned his Medical Doctorate from the Universitat Autònoma de Barcelona in 2003 and later completed a PhD Cum Laude in Medicine, focusing on intracranial atherostenosis. He has held senior neurology positions at prestigious hospitals in Spain, including Hospital Universitari Vall d’Hebron, Jiménez Díaz Foundation, and Hospital Universitari Mútua Terrassa, where he currently serves. Dr. Massot Tarrús has specialized expertise in epilepsy, EEG, and cerebrovascular diseases and has completed advanced fellowships in Canada and the UK.

Professional Profile 

Education

Andreu Massot Tarrús earned his Medical Doctorate in August 2003 from the Universitat Autònoma de Barcelona. He went on to complete his Neurology specialization in May 2009 at the Hospital Universitari Vall d’Hebron, Barcelona. In June 2013, he was awarded a PhD Cum Laude in Medicine by the same university for his thesis on intracranial atherostenosis, supervised by Dr. Montaner Villalonga and Dr. Álvarez-Sabín. His commitment to epilepsy research led him to a Clinical and Research Fellowship in Epilepsy and EEG at Western University, Ontario, in 2014, followed by a Master in Epilepsy from the Universidad de Murcia in 2018, where he received an excellent qualification.

 Work Experience

Dr. Massot Tarrús’s medical career has spanned several prestigious institutions. Starting as a clinical observer in London (2008), he then became a Senior Neurologist in Barcelona and Madrid, working in the Neurovascular Unit at Vall d’Hebron (2009-2010) and the Epilepsy Unit at the Jiménez Díaz Foundation (2010-2011). Between 2011 and 2021, he took on various senior roles, including at Hospital del Mar and Hospital Universitario Gregorio Marañón, Madrid. Since September 2021, he has been a Senior Neurologist and Epileptologist at Hospital Universitari Mútua Terrassa, where he continues to excel in treating neurological disorders, particularly epilepsy.

 Skills 

Dr. Massot Tarrús is highly skilled in Electroencephalography (EEG) and Video-EEG monitoring. He has extensive experience in intraoperative electrocorticography, cortical stimulation mapping, and the Wada test. His expertise in cerebrovascular diseases and ultrasonography diagnostics has made him a leading lecturer at several top hospitals, including Vall d’Hebron, Hospital del Mar, and Hospital Gregorio Marañón.

Awards & Honors

He holds certifications in Electroencephalography from both the Canadian Society of Clinical Neurophysiology (2015) and the Spanish Society of Neurology (2016). He was also awarded a Cum Laude distinction for his doctoral work and has participated in advanced training like the NIH Stroke Scale Training by the National Stroke Association.

 Membership 

Dr. Massot Tarrús is an active member of the Spanish Society of Neurology and has contributed significantly to clinical neurophysiology through his memberships in various international medical bodies.

 Teaching Experience

Dr. Massot Tarrús has shared his knowledge extensively, offering lectures on epilepsy, neurovascular diseases, and ultrasonography techniques. He has taught at institutions like Jiménez Díaz Foundation, Hospital del Mar, and Western University, where his work in EEG and cerebrovascular illness has helped shape the careers of future neurologists.

 Research Focus

His research primarily focuses on epilepsy and ischemic cerebrovascular diseases. His PhD thesis, which examined markers of recurrence in intracranial atherostenosis, highlights his dedication to improving diagnostics and treatment outcomes in neurology. He continues to contribute to research on epilepsy and cerebrovascular conditions, aiming to reduce the recurrence of ischemic events in patients.

 

📖Publications : 

  • 📄 “Real-world safety and effectiveness of cenobamate in patients with focal onset seizures: Outcomes from an Expanded Access Program”
    Author: Massot-Tarrús, A.
    Journal: Epilepsia Open
    Year: 2023
    Volume: 8(3), pp. 918–929
  • 📊 “Risk factors for comorbid epilepsy in patients with psychogenic non-epileptic seizures. Dataset of a large cohort study”
    Author: Massot-Tarrús, A.
    Journal: Data in Brief
    Year: 2022
    Volume: 45, 108568
  • 🧠 “Roles of fMRI and Wada tests in the presurgical evaluation of language functions in temporal lobe epilepsy”
    Author: Massot-Tarrús, A.
    Journal: Frontiers in Neurology
    Year: 2022
    Volume: 13, 884730
  • 💊 “Perampanel as adjuvant treatment in epileptic encephalopathies: A multicenter study in routine clinical practice”
    Co-author: Massot-Tarrús, A.
    Journal: Epilepsy and Behavior
    Year: 2022
    Volume: 134, 108836
  • 📈 “Factors associated with comorbid epilepsy in patients with psychogenic nonepileptic seizures: A large cohort study”
    Author: Massot-Tarrús, A.
    Journal: Epilepsy and Behavior
    Year: 2022
    Volume: 134, 108780
  • 🧩 “Cortical myoclonus associated with coeliac disease showing a characteristic EEG pattern: A case report”
    Author: Massot-Tarrús, A.
    Journal: Seizure
    Year: 2022
    Volume: 95, pp. 81–83
  • 🚑 “Response to anakinra in new-onset refractory status epilepticus: A clinical case”
    Author: Massot-Tarrús, A.
    Journal: Seizure
    Year: 2022
    Volume: 94, pp. 92–94
  • 🦠 “Neurological complications of COVID-19 in hospitalized patients: The registry of a neurology department in the first wave of the pandemic”
    Co-author: Massot-Tarrús, A.
    Journal: European Journal of Neurology
    Year: 2021
    Volume: 28(10), pp. 3339–3347
  • 📉 “Predicting outcome of patients with psychogenic nonepileptic seizures after diagnosis in an epilepsy monitoring unit”
    Author: Massot-Tarrús, A.
    Journal: Epilepsy and Behavior
    Year: 2021
    Volume: 120, 108004
  • 🧬 “E200K familial Creutzfeldt-Jakob disease. MRI, EEG, PET and neuropathological correlation in a family”
    Co-author: Massot-Tarrús, A.
    Journal: Neurologia
    Year: 2021
    Volume: 36(5), pp. 399–401

 

Dr Roberta Gasparro | Neuroscience | Best Paper Award

Posted on by sciencefather

Dr Roberta Gasparro | Neuroscience | Best Paper Award 🏆

Research Fellow at University of Naples Federico II , Italy🎓

Dr. Roberta Gasparro, born in 1988, is a distinguished professional in the field of Dentistry and Oral Surgery. She is a resident of Laureana Cilento, Salerno, Italy. Dr. Gasparro has established herself as a highly qualified dentist and researcher, recognized for her significant contributions to clinical and experimental medicine.

Professional Profile 

Education🎓

Dr. Gasparro began her academic journey with a Scientific High School Diploma in 2007, achieving top marks. She then pursued Biotechnology Sciences at the University of Naples Federico II, later transitioning to Dentistry and Dental Prosthetics. She graduated in 2013 with the highest honors, receiving special mention and publication dignity. In 2017, she earned a PhD in “Clinical and Experimental Medicine” from the same university. Her education was further enhanced by an Advanced Training Course in Oral and Reconstructive Surgery in 2023.

 💼Work Experience

Dr. Gasparro has held various prestigious positions throughout her career. After obtaining her degree, she worked as a Research Fellow at the University of Naples Federico II in the Department of Neurosciences, Reproductive, and Odontostomatological Sciences. In 2019, she was ranked first in the competition for the Specialization in Oral Surgery. Currently, she serves as a Contract Professor at the University of Salerno, where she teaches Odontostomatological Clinic modules in the Integrated Therapy courses.

 🛠️Skills

Dr. Gasparro’s skills include expertise in Oral Surgery, Implantology, and Maxillofacial Pathology and Therapy. Her academic background and practical experience have equipped her with advanced knowledge in clinical and experimental dentistry, as well as a deep understanding of complex surgical procedures.

 🏆Awards and Honors

Dr. Gasparro’s excellence has been recognized with several awards, particularly for her oral presentations and poster contributions at national and international conferences. Her work has earned her multiple honors, including being a recipient of special mention for her degree and PhD achievements.

 Membership 🏛️and Affiliations 🤝

As an active member of various national and international scientific societies, Dr. Gasparro holds several responsibilities, contributing to the advancement of dental and medical sciences. Her involvement in these organizations reflects her commitment to staying at the forefront of her field.

 Teaching Experience👨‍🏫

Dr. Gasparro has extensive teaching experience, having served as a Contract Professor at the University of Salerno since 2020. She has taught the Odontostomatological Clinic module in both Integrated Therapy I and II courses for the Master’s Degree in Dentistry and Dental Prosthetics. Her teaching has been highly regarded, and she continues to contribute to the education of future dental professionals.

 Research Focus 🔬

Dr. Gasparro’s research is focused on clinical and experimental medicine, with a particular emphasis on Oral Surgery, Implantology, and Maxillofacial Pathology. She has authored 53 publications in indexed and impact-factor journals, with an H index of 13 and a total of 536 citations, underscoring the impact of her research. Her work has been published in high-ranking journals, including 13 Q1 articles, one of which is in the top decile.

📖Publications : 

  • The role of cognitive and non‐cognitive factors in dental anxiety: A mediation model
    🗓️ 2021
    📘 European Journal of Oral Sciences
    ✍️ Authors: C. Scandurra, R. Gasparro, P. Dolce, V. Bochicchio, B. Muzii, G. Sammartino, …

 

  • Treatment of periodontal pockets at the distal aspect of mandibular second molar after surgical removal of impacted third molar and application of L-PRF: A split-mouth study
    🗓️ 2020
    📘 Quintessence International
    ✍️ Authors: R. Gasparro, G. Sammartino, M. Mariniello, A. Espedito di Lauro, …

 

  • Rhein: A novel antibacterial compound against Streptococcus mutans infection
    🗓️ 2022
    📘 Microbiological Research
    ✍️ Authors: V. Folliero, F. Dell’Annunziata, E. Roscetto, A. Amato, R. Gasparro, …

 

  • Multidisciplinary approach to fused maxillary central incisors: A case report
    🗓️ 2014
    📘 Journal of Medical Case Reports
    ✍️ Authors: G. Sammartino, V. Cerone, R. Gasparro, F. Riccitiello, O. Trosino

 

  • Use of injectable platelet‐rich fibrin in the treatment of plasma cell mucositis of the oral cavity refractory to corticosteroid therapy: A case report
    🗓️ 2019
    📘 Dermatologic Therapy
    ✍️ Authors: R. Gasparro, D. Adamo, M. Masucci, G. Sammartino, M.D. Mignogna

 

  • Three-dimensional cell cultures: The bridge between in vitro and in vivo models
    🗓️ 2023
    📘 International Journal of Molecular Sciences
    ✍️ Authors: O. Urzì, R. Gasparro, E. Costanzo, A. De Luca, G. Giavaresi, S. Fontana, …

 

  • Burning fog: Cognitive impairment in burning mouth syndrome
    🗓️ 2021
    📘 Frontiers in Aging Neuroscience
    ✍️ Authors: F. Canfora, E. Calabria, R. Cuocolo, L. Ugga, G. Buono, G. Marenzi, …

 

  • Peri-implant soft tissue management: Cairo opinion consensus conference
    🗓️ 2020
    📘 International Journal of Environmental Research and Public Health
    ✍️ Authors: F.S.L. Del Amo, S.H. Yu, G. Sammartino, A. Sculean, G. Zucchelli, G. Rasperini, …

 

  • Effectiveness of surgical procedures in the acceleration of orthodontic tooth movement: Findings from systematic reviews and meta‐analyses
    🗓️ 2022
    📘 Japanese Dental Science Review
    ✍️ Authors: R. Gasparro, R. Bucci, F. De Rosa, G. Sammartino, P. Bucci, V. D’Antò, …

 

  • The use of piezosurgery in genioplasty
    🗓️ 2016
    📘 Journal of Craniofacial Surgery
    ✍️ Authors: R. Rullo, V.M. Festa, F. Rullo, O. Trosino, V. Cerone, R. Gasparro, L. Laino, …

 

  • Platelet‐rich plasma counteracts detrimental effect of high‐glucose concentrations on mesenchymal stem cells from Bichat fat pad
    🗓️ 2020
    📘 Journal of Tissue Engineering and Regenerative Medicine
    ✍️ Authors: V. D’Esposito, M. Lecce, G. Marenzi, S. Cabaro, M.R. Ambrosio, …

 

  • Clinical relevance of bone density values from CT related to dental implant stability: A retrospective study
    🗓️ 2018
    📘 BioMed Research International
    ✍️ Authors: V. Bruno, C. Berti, C. Barausse, M. Badino, R. Gasparro, D.R. Ippolito, …

 

  • Four-year post-loading results of full-arch rehabilitation with immediate placement and immediate loading implants: A retrospective controlled study
    🗓️ 2017
    📘 Quintessence International
    ✍️ Authors: A. Simonpieri, R. Gasparro, G. Pantaleo, J. Mignogna, F. Riccitiello, …

 

Marjan Shariatpanahi | Neuroscience | Best Researcher Award

Posted on by sciencefather

Dr Marjan Shariatpanahi |  Neuroscience | Best Researcher Award 

Associate professor at Iran university of medical sciences,Iran

Dr. Marjan Shariatpanahi is an Associate Professor in the Department of Pharmacology and Toxicology at the School of Pharmacy, Iran University of Medical Sciences, Tehran, Iran. With extensive experience in toxicology and pharmacology, Dr. Shariatpanahi has made significant contributions to research on neurodegenerative diseases and toxicology.

professional profile

scopus

google scholar

Education 🎓

Dr. Shariatpanahi holds a Doctor of Pharmacy (Pharm. D.) from Islamic Azad University, Tehran (2000-2006) with a thesis on thymidine phosphorylase and estrogen receptor alpha in colorectal cancer. She also earned a Ph.D. in Toxicology from Tehran University of Medical Sciences (2009-2014), focusing on the effects of PKG on spatial memory deficits and markers of autophagy and apoptosis in rats.

Work Experience 🏥

Dr. Shariatpanahi has a diverse professional background. She has been the Head of the Pharmacology & Toxicology Department at Iran University of Medical Sciences since 2017. Her previous roles include Dean of the Educational Office (2020-2023), Head of Student and Cultural Affairs (2019-2020), and faculty member at the Neuroscience Research Center (2018-present). She has also worked as an Assistant Professor at both Iran University of Medical Sciences and Guilan University of Medical Sciences, and as a Responsible Pharmacist in various institutions.

Skills 🛠️

Dr. Shariatpanahi is proficient in various research techniques, including IHC, Western blot, ICC, in vivo studies, and behavioral tests for neurodegenerative diseases. Her expertise extends to TLC, spectrophotometry, SPSS, PRISM, ELISA, and gas chromatography. She is also skilled in using atomic absorption machines and Endnote.

Awards and Honors 🏅

Dr. Shariatpanahi has received several accolades, including being named the best professor at the Vosough Festival of IUMS (2023) and being recognized as a selected pharmacist (2022). She was also acknowledged as a top student in toxicology and pharmacy, receiving first ranks in board examinations and seminars.

Professional Memberships 🔗

Dr. Shariatpanahi is a member of the Iranian Association of Toxicology, the Iranian Medical Council, the Iranian Association of Pharmacists, the Iranian Probiotics Society, and the Talent Society of Tehran University.

Teaching Experience 📚

Dr. Shariatpanahi has taught a wide range of courses across various levels. For Ph.D. students, she covers basics of pharmacology. For Doctor of Pharmacy students, she teaches toxicology, pharmacology, clinical toxicology, and specialized pharmacy language. Her M.Sc. teaching includes environmental toxicology, forensic toxicology, and advanced research methods, while for B.Sc. students, she focuses on toxicology.

Research Focus 🔬

Dr. Shariatpanahi’s research interests include neuroscience, with a focus on autism, Alzheimer’s disease, memory, and Parkinson’s disease. She is also involved in toxicology, environmental toxicology, pharmacology, cell signaling, stem cell therapy, and the study of behavioral investigations on animals. Her work explores various markers and mechanisms in carcinogenesis, angiogenesis, and the protective and toxic effects of nanoparticles.

Conclusion

Dr. Marjan Shariatpanahi’s extensive qualifications, leadership roles, significant research contributions, and recognition in the field make him an excellent candidate for the Best Researcher Award. His achievements demonstrate a strong commitment to advancing knowledge in pharmacology and toxicology, contributing valuable insights into neurodegenerative diseases, toxicology, and pharmacology.

publication 

 

Lianyan Huang | Neuroscience | Best Researcher Award

Posted on by sciencefather

 Prof Lianyan Huang | Neuroscience | Best Researcher Award

professor / Ph.D. advisor at Sun-yat sen university Guangzhou, China

Dr. Lianyan Huang is a professor at Zhongshan School of Medicine, Sun Yat-sen University, with expertise in neuroscience. She completed her postdoctoral training at NYU and has received numerous honors, including the Guangdong Provincial Award. Her research focuses on neural coding mechanisms and neurological disorders, with key findings published in top journals. 🧠📚🏆

professional profile :

Awards and Honors

10th SCBA Meeting Scholarship (2004) 🏅Excellent Postgraduate Scholarships of Guangdong Province (2006, 2009) 🎓Academician Scholarship of Southern Medical University (2006) 🏆Guangdong Provincial Award for Outstanding Young and Middle-Aged Clinical Medical Teachers (2023) 🏆

Professional Work Experience

Professor and Ph.D. Advisor, Zhongshan School of Medicine, Sun Yat-sen University (2017-present) 👩‍🏫Postdoctoral Fellow, NYU School of Medicine (2012-2017) 🧠Faculty and Lecturer, Southern Medical University (2008-2011) 👩‍🏫Graduate Research Assistant, The First Military Medical University (2003-2006) 👩‍🔬

Skills

Neuroscience Research 🧠Clinical Medicine 🩺Cell Biology 🔬Teaching and Advising 🎓Leadership in Professional Committees 👩‍🏫

Other Experience and Professional Memberships

  • 2006-present: Member, Society for Neuroscience of China 🧠🔬

publication:

Pain experience reduces social avoidance to others in pain: a c-Fos-based functional connectivity network study in mice

📅 2024 📰 Cerebral Cortex 🧠

Authors: Li, J., Qin, Y., Zhong, Z., Huang, L., Li, B.

Sexually dimorphic control of affective state processing and empathic behaviors

📅 2024 📰 Neuron 🧠

Authors: Fang, S., Luo, Z., Wei, Z., Huang, L., Li, B.

An insular cortical circuit required for itch sensation and aversion

📅 2024 📰 Current Biology 🧬

Authors: Zheng, J., Zhang, X.M., Tang, W., Huang, L., Li, B.

EF1α-associated protein complexes affect dendritic spine plasticity by regulating microglial phagocytosis in Fmr1 knock-out mice

📅 2024 📰 Molecular Psychiatry 🧠

Authors: Su, P., Yan, S., Chen, K., Yang, G., Liu, F.

Differences in the neural basis and transcriptomic patterns in acute and persistent pain-related anxiety-like behaviors

📅 2023 📰 Frontiers in Molecular Neuroscience 🧬

Authors: Fang, S., Qin, Y., Yang, S., Li, B., Huang, L.

Distinct behavioral traits and associated brain regions in mouse models for obsessive–compulsive disorder

📅 2021 📰 Behavioral and Brain Functions 🧠

Authors: Chen, X., Yue, J., Luo, Y., Li, B., Wen, S.

Enriched Environment Prevents Surgery-Induced Persistent Neural Inhibition and Cognitive Dysfunction

📅 2021 📰 Frontiers in Aging Neuroscience 🧬

Authors: Yang, S., Zhang, S., Tang, W., Huang, L., Li, B.

BDNF produced by cerebral microglia promotes cortical plasticity and pain hypersensitivity after peripheral nerve injury

📅 2021 📰 PLoS Biology 🔬

Authors: Huangi, L., Jin, J., Chen, K., Gan, W.-B., Yang, G.

Learning-dependent dendritic spine plasticity is impaired in spontaneous autoimmune encephalomyelitis

📅 2021 📰 Developmental Neurobiology 🧠

Authors: Huang, L., Lafaille, J.J., Yang, G.

Learning-Dependent Dendritic Spine Plasticity Is Reduced in the Aged Mouse Cortex

📅 2020 📰 Frontiers in Neural Circuits 🧬

Authors: Huang, L., Zhou, H., Chen, K., Chen, X., Yang, G.